Stämm

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://stamm.bio/

Last Round

Series A

Mar 1, 2022

Total Funding Raised

$19.25M

Company Overview

Stämm is a biotechnology company that has developed a novel bioproduction system designed to scale up the biotech industry using microfluidics, electroporation, and robotics.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Smart Manufacturing, 3D Printing, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

continuous biomanufacturingmicrofluidicsbioprocessordecentralized manufacturingcell therapy manufacturingautomated bioprocessing3D bioprintingcultivated meatlab-grown meatbiologics manufacturingmammalian cell culturecellular agriculturelaminar flowcontract development manufacturingCDMOdesktop biomanufacturingcell predictive modelingcell line development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stämm Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Stämm Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Mar 1, 2022
Seed	Jun 27, 2019
Accelerator	Jul 25, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Yuyo Llamazares Vegh

CEO Founder

Founding Team

Juan Martin Cabaleiro

Chief Technology Officer

Executive Team

Federico D'Alvia Vegh

Fundador Y COO

Executive Team

Stämm Investors

Notable investors and investment history

Investor	Rounds
Varana Capital	Series A
IndieBio	Accelerator
Draper Associates	Series A, Seed
Draper Cygnus	Series A
SOSV	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 12, 2026
Launched the High-Throughput Bioprocessor (HTB) for biomanufacturing.
Aug 13, 2025
Developing the Multi-omic Network Atlas (MoNA) platform.

View all signals

Stämm Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Stämm Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Stämm's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range161

Year Founded2014

Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.